# | ||||
---|---|---|---|---|
1 | PROCROP Professional cross-priming for ovary and prostate cancer | 2015 | 7˙572˙500.00 | 5˙750˙000.00 |
2 | TARGEPILIVER Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs. | 2015 | 170˙121.00 | 170˙121.00 |
3 | CINK Advancing cancer immunotherapy using natural killer cells for hematological and metastatic cancers | 2018 | 158˙121.00 | 158˙121.00 |
4 | NONCHROREP Investigating the role of the long noncoding transcriptome in chromatin replication | 2018 | 2˙000˙000.00 | 2˙000˙000.00 |
5 | LINKER Elucidating transcriptional rewiring on hematological malignancies via computational methods | 2020 | 172˙932.00 | 172˙932.00 |
6 | SYLENCE Synapses between Leukaemia and its Neighbouring Cells | 2020 | 160˙932.00 | 160˙932.00 |
The Institution FUNDACION PARA LA INVESTIGACION MEDICA APLICADA FIMA has been involved also in the following Horizon 2020 projects.